Accuray Incorporated (ARAY)

Etorro trading 970x250
Accuray Incorporated (ARAY) Logo

About Accuray Incorporated

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, including the Radixact System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California. Address: 1310 Chesapeake Terrace, Sunnyvale, CA, United States, 94089

Accuray Incorporated News and around…

Latest news about Accuray Incorporated (ARAY) common stock and company :

After Golden Cross, Accuray (ARAY)'s Technical Outlook is Bright
25 Nov, 2021 Yahoo! Finance

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

Earnings Estimates Rising for Accuray (ARAY): Will It Gain?
17 Nov, 2021 Yahoo! Finance

Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Here's What Could Help Accuray (ARAY) Maintain Its Recent Price Strength
17 Nov, 2021 Yahoo! Finance

If you are looking for stocks that are well positioned to maintain their recent uptrend, Accuray (ARAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery
10 Nov, 2021 Yahoo! Finance

Accuray Incorporated (NASDAQ: ARAY) announced today that more than two decades of globally-driven clinical data support the use of the company's CyberKnife® robotic radiotherapy platform for the delivery of stereotactic radiosurgery (SRS) treatments for neurological diseases. The most recent CyberKnife data, an analysis of 7,000 patients with brain or spinal lesions treated at Stanford University School of Medicine, was published online in the Journal of Neurosurgery. The non-invasive platform p

Accuray To Participate at Stifel 2021 Virtual Healthcare Conference
09 Nov, 2021 Yahoo! Finance

Accuray Incorporated (Nasdaq: ARAY) today announced its participation in Stifel's 2021 Virtual Healthcare Conference. The management team is scheduled to present on Tuesday, November 16th, 2021 at 6:20 am PACIFIC / 9:20 am EASTERN.

3 Penny Stocks To Add to Your Watchlist This Month November
06 Nov, 2021 FinancialContent
Accuray (ARAY) Q1 Earnings Beat Estimates, Margins Down
04 Nov, 2021 Yahoo! Finance

Accuray (ARAY) registers growth in both Service and Product revenues during fiscal Q1.

Accuray Incorporated (ARAY) Q1 2022 Earnings Call Transcript
04 Nov, 2021 FinancialContent

ARAY earnings call for the period ending September 30, 2021.

Accuray Reports Fiscal 2022 First Quarter Financial Results
03 Nov, 2021 Yahoo! Finance

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2022 ended September 30, 2021.

Global Metastatic Cancer Treatment Market Size Is Forecasted To Reach $111.16 Million By 2027
03 Nov, 2021 FinancialContent
Notable Friday Option Activity: PPC, LMT, ARAY
29 Oct, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Pilgrims Pride Corp. (PPC), where a total volume of 3,797 contracts has been traded thus far today, a contract volume which is representative of approximately 379,700 underlying shares (given that every 1 contract represents 100 underlying shares)..

Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients
25 Oct, 2021 Yahoo! Finance

Accuray Incorporated (NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients could experience significant improvements in survival if treated with accelerated partial breast irradiation (APBI) delivered using the Accuray CyberKnife® robotic radiotherapy platform. Study investigators performed complex modeling that also indicates the survival rate could be better with CyberKnife APBI than other radiation delivery approaches including

12 Health Care Stocks Moving In Friday's Intraday Session
22 Oct, 2021 FinancialContent

Gainers Progenity (NASDAQ:PROG) stock increased by 18.48% to $2.96 during Friday's regular session. Progenity's ...

Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range between $420 million to $427 million
21 Oct, 2021 Yahoo! Finance

Accuray Incorporated (NASDAQ: ARAY), today announced preliminary financial results for the first quarter of fiscal 2022 ended September 30, 2021.

Accuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at ASTRO 2021
19 Oct, 2021 Yahoo! Finance

Accuray Incorporated (NASDAQ: ARAY) announced today the company is showcasing its new VOLO™ Ultra for the Radixact® System, at ASTRO 2021. VOLO Ultra, a new way of planning with the Accuray Precision® Treatment Planning System, enables users to plan with ease, optimize with quality, and deliver treatments with efficiency. The American Society for Radiation Oncology's (ASTRO) 63rd annual meeting will take place October 24-27, 2021, in Chicago. Accuray will be in attendance at booth #403, sharing

Accuray to Report First Quarter Fiscal 2022 Financial Results on November 3, 2021
13 Oct, 2021 Yahoo! Finance

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2022, ended September 30, 2021, after the market close on Wednesday, November 3, 2021. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. ET on the same day.

Accuray (ARAY), C-RAD Ink Deal to Enhance Breast Cancer Treatment
12 Oct, 2021 Yahoo! Finance

Accuray's (ARAY) latest agreement is likely to improve breast cancer treatment.

Accuray to Host ASTRO Analyst & Investor Meeting on October 25, 2021
12 Oct, 2021 Yahoo! Finance

Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host an Analyst & Investor Meeting on Monday, October 25, 2021, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting. The event will take place in person at the ASTRO meeting and on a virtual platform, with presentations beginning at 3:00 pm CT (4:00 pm ET).

Accuray's (ARAY) Radiotherapy Technologies Adopted by Unicancer
05 Oct, 2021 Yahoo! Finance

Accuray's (ARAY) proprietary radiotherapy technologies get selected by Unicancer, which is the largest network of comprehensive cancer centers in Europe.

Accuray Inks Deal with C-RAD to Enhance Breast Cancer Treatment
05 Oct, 2021 Yahoo! Finance

Accuray Incorporated (ARAY), focused on solutions for radiation treatments, has entered into an agreement with Sweden-based C-RAD, the provider of innovative solutions for use in advanced radiation therapy, to enhance its Radixact System’s capabilities to treat breast cancer. Shares of the company declined 5.7% in extended trade on Monday. The Accuray Radixact System is the next generation TomoTherapy platform, which delivers radiation therapy to treat breast cancer at almost every stage and has

Accuray (NASDAQ:ARAY) Is Experiencing Growth In Returns On Capital
05 Oct, 2021 Yahoo! Finance

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

C-RAD and Accuray Sign Agreement to Enhance Radixact® System Breast Cancer Treatment Capabilities
04 Oct, 2021 Yahoo! Finance

C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed an agreement designed to enhance the Accuray Radixact® System's ability to treat breast cancer. The companies will partner to provide customers with a solution for deep inspiration breath hold (DIBH)* using the C-RAD Catalyst+ HD and Radixact System. DIBH is a technique frequently used for breast cancer treatments. The development work will commence before the end of 2021 with the first i

French Hospital Network Unicancer Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies
29 Sep, 2021 Yahoo! Finance

Accuray Incorporated (NASDAQ: ARAY) announced today that Unicancer has selected three Radixact® Systems with the ClearRT™ helical fan-beam kVCT imaging and Synchrony® real-time delivery adaptation technologies to further their goal of providing truly personalized care to every cancer patient. The Unicancer team began leveraging the benefits of the TomoTherapy® helical radiotherapy delivery platform more than 15 years ago. The Radixact System, based on the TomoTherapy platform, ClearRT and Synchr

2 “Strong Buy” Penny Stocks That Are Headed to a Triple-Digit Gain
23 Sep, 2021 Yahoo! Finance

Every investor wants to find the best market returns, and they’ll follow a variety of strategies to get there. One common strategy – and one that offers plenty of promise for investors who don’t mind shouldering the extra risk – is to go after penny stocks. Traditionally seen as stocks priced for just pennies per share, these equities are now defined as those with a share price of $5 or less. For the tough-minded investors, these low-cost stocks present a combination of risk/reward that few othe

The Math Shows EES Can Go To $56
07 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the WisdomTree US.

Ooma Shares Shoot Up As Analysts See Up To 52% Upside Post Q2 Beat
03 Sep, 2021 FinancialContent

Ooma Inc(NYSE: OOMA)reported Q2 revenueof $47.1 million, up 14% year-on-year, beating the analyst consensus of ...

58 Biggest Movers From Friday
23 Aug, 2021 FinancialContent

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell ...

38 Stocks Moving In Friday's Mid-Day Session
20 Aug, 2021 FinancialContent

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares climbed 45.8% to $6.27 after the company presented data from ongoing studies of ...

Accuray Incorporated (ARAY) Q4 2021 Earnings Call Transcript
12 Aug, 2021 FinancialContent

ARAY earnings call for the period ending June 30, 2021.

EES's Holdings Imply 14% Gain Potential
03 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the WisdomTree US.

Accuray Incorporated (ARAY) is a NASDAQ Common Stock listed in , ,

970x250